Exicure, Inc. (XCUR)
NASDAQ: XCUR · Real-Time Price · USD
3.570
+0.020 (0.56%)
At close: Mar 4, 2026, 4:00 PM EST
3.710
+0.140 (3.92%)
Pre-market: Mar 5, 2026, 8:35 AM EST
Exicure Market Cap
Exicure has a market cap or net worth of $22.75 million as of March 5, 2026. Its market cap has decreased by -25.35% in one year.
Market Cap
22.75M
Enterprise Value
18.68M
1-Year Change
-25.35%
Ranking
Category
Stock Price
$3.57
Market Cap Chart
Since May 22, 2018, Exicure's market cap has decreased from $122.31M to $22.75M, a decrease of -81.40%. That is a compound annual growth rate of -19.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 3, 2026 | 22.63M | -34.50% |
| Dec 31, 2025 | 34.55M | -16.84% |
| Dec 31, 2024 | 41.54M | 727.79% |
| Dec 29, 2023 | 5.02M | -12.10% |
| Dec 30, 2022 | 5.71M | -72.06% |
| Dec 31, 2021 | 20.44M | -86.82% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| May 22, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Senti Biosciences | 25.00M |
| Lixte Biotechnology Holdings | 24.83M |
| Barinthus Biotherapeutics | 24.50M |
| IO Biotech | 24.43M |
| Vistagen Therapeutics | 24.17M |
| Skye Bioscience | 23.59M |
| Neuphoria Therapeutics | 23.45M |
| Marker Therapeutics | 22.84M |